Search
for
Sort by
Research 631–660 of 1000+
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Incorporation of Isotopically Labeled Cocaine and Metabolites into Human Hair: 1. Dose-Response Relationships
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Effectiveness of Non-SLS Shampoo Based on VCO and Tectona grandis Leaf Extract for Alopecia Treatment
- Nothopanax scutellarium: Natural Hair Growth Plant
- Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth
- ERK1/2 Pathway Is Involved in the Enhancement of Fatty Acids from Phaeodactylum tricornutum Extract (PTE) on Hair Follicle Cell Proliferation
- Melatonin Promotes the Development of Secondary Hair Follicles in Adult Cashmere Goats by Activating the Keap1-Nrf2 Signaling Pathway and Inhibiting the Inflammatory Transcription Factors NFκB and AP-1
- Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review
- Dynamics of procollagen type 1 N-terminal propeptide in postmenopausal osteoporosis during bisphosphonate therapy and transcranial electrical stimulation
- Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 1 approved]
- Comparing the Effectiveness of Local Solution of Minoxidil and Caffeine 2.5% with Local Solution of Minoxidil 2.5% in Treatment of Androgenetic Alopecia
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Is There An Association Between 25(OH)D Serum Levels and Vitamin D Status with The Severity of Androgenetic Alopecia Severity in Men?
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2
- The BLMP-1 transcription factor promotes oscillatory gene expression to achieve timely molting
- Evaluation of serum level of omentin‐1 in females with hirsutism
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- The role of Paraoxonase 1 in Alopecia Areata, a Marker and a Severity Index
- Comparative study of the efficacy of finasteride 1 mg/d on different age groups with androgenetic alopecia using phototrichogram analysis. A single-center retrospective analysis
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Development and optimization of biotinoyl tripeptide-1 loaded solid lipid nanoparticles for protection against heat induced hair damage
- Editorial: Vitamin D 1α-Hydroxylase Knockout Mice as a Hereditary Rickets Animal Model
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2